These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 31368789)

  • 1. Ethical complexities of responding to bystander risk in HIV prevention trials.
    Eyal N; Wikler D
    Clin Trials; 2019 Oct; 16(5):458-460. PubMed ID: 31368789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex partners as bystanders in HIV prevention trials: Two test cases for research ethics.
    Bärnighausen T
    Clin Trials; 2019 Oct; 16(5):455-457. PubMed ID: 31368799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical Issues to Consider in the Design of HIV Prevention Trials Involving Transgender People.
    Singh JA
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 3(Suppl 3):S252-5. PubMed ID: 27429192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research bystanders, justice, and the state: Reframing the debate on third-party protections in health research.
    Murphy N; Weijer C
    Bioethics; 2022 Oct; 36(8):865-873. PubMed ID: 35839382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study bystanders and ethical treatment of study participants-A proof of concept.
    Eyal N
    Bioethics; 2020 Nov; 34(9):941-947. PubMed ID: 33103813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. South African Research Ethics Committee Review of Standards of Prevention in HIV Vaccine Trial Protocols.
    Essack Z; Wassenaar DR
    J Empir Res Hum Res Ethics; 2018 Jul; 13(3):239-246. PubMed ID: 29631486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent Self-Consent for Biomedical Human Immunodeficiency Virus Prevention Research.
    Gilbert AL; Knopf AS; Fortenberry JD; Hosek SG; Kapogiannis BG; Zimet GD
    J Adolesc Health; 2015 Jul; 57(1):113-9. PubMed ID: 26095412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethics and HIV prevention research: An analysis of the early tenofovir PrEP trial in Nigeria.
    Peterson K; Folayan MO
    Bioethics; 2019 Jan; 33(1):35-42. PubMed ID: 30198594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minors' and Young Adults' Experiences of the Research Consent Process in a Phase II Safety Study of Pre-exposure Prophylaxis for HIV.
    Knopf AS; Ott MA; Liu N; Kapogiannis BG; Zimet GD; Fortenberry JD; Hosek SG
    J Adolesc Health; 2017 Dec; 61(6):747-754. PubMed ID: 28967541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulating impact on bystanders in clinical trials: An unsettled frontier.
    Eyal N; Kimmelman J; Holtzman LG; Lipsitch M
    Clin Trials; 2019 Oct; 16(5):450-454. PubMed ID: 31368813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?
    Venter F; Allais L; Richter M
    Bioethics; 2014 Jul; 28(6):269-74. PubMed ID: 23796241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the ethical-legal framework for adolescent HIV vaccine trials--report of a consultative forum.
    Slack C; Strode A; Grant C; Milford C
    S Afr Med J; 2005 Sep; 95(9):682-4. PubMed ID: 16327927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical Implications of Social Stigma Associated with the Promotion and Use of Pre-Exposure Prophylaxis for HIV Prevention.
    Herron PD
    LGBT Health; 2016 Apr; 3(2):103-8. PubMed ID: 26859191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risky research and bystander consent.
    Hanser M
    Bioethics; 2020 Nov; 34(9):912-917. PubMed ID: 32989753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbicide research in developing countries: have we given the ethical concerns due consideration?
    Moodley K
    BMC Med Ethics; 2007 Sep; 8():10. PubMed ID: 17877834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually transmitted infections among high-risk populations that use treatment as prevention or pre-exposure prophylaxis: a protocol for a systematic review.
    Coudray M; Kiplagat S; Saumell F; Madhivanan P
    BMJ Open; 2019 Dec; 9(12):e032054. PubMed ID: 31811008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Offering pre-exposure prophylaxis for HIV prevention to pregnant and postpartum women: a clinical approach.
    Seidman DL; Weber S; Cohan D
    J Int AIDS Soc; 2017 Mar; 20(Suppl 1):21295. PubMed ID: 28361503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polarised press reporting about HIV prevention: Social representations of pre-exposure prophylaxis in the UK press.
    Jaspal R; Nerlich B
    Health (London); 2017 Sep; 21(5):478-497. PubMed ID: 27216725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Considerations for a Human Rights Impact Assessment of a Population Wide Treatment for HIV Prevention Intervention.
    Hanefeld J; Bond V; Seeley J; Lees S; Desmond N
    Dev World Bioeth; 2015 Dec; 15(3):115-24. PubMed ID: 26524615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.